Latest News

  • PARTNERSHIPS

    25 Nov 2025

    The Push to Turn mRNA Into a Cancer Weapon

  • INSIGHTS

    24 Nov 2025

    Moderna’s Homegrown Bet Could Rewire Biotech’s Future

  • REGULATORY

    20 Nov 2025

    US MRNA Leaders Push for Regulatory Modernization as Innovation Surges

  • PARTNERSHIPS

    18 Nov 2025

    New Alliance Aims to Steady the mRNA Supply Chain

Can mRNA Rewrite the Future of Rare Disease Care?

mRNA strand connecting to virus and syringe representing genetic therapy

INNOVATION

14 Nov 2025

US labs and biotech firms push mRNA deeper into rare disease therapy, stirring hope and investment

Syringe drawing dose from medical vial for mRNA vaccine research

PARTNERSHIPS

25 Nov 2025

The Push to Turn mRNA Into a Cancer Weapon

Pfizer and BioNTech deepen mRNA cancer vaccine development as competition grows and FDA signals supportive pathways

Automated production line filling COVID-19 vaccine vials in a sterile facility.

INSIGHTS

24 Nov 2025

Moderna’s Homegrown Bet Could Rewire Biotech’s Future

Moderna boosts US mRNA production, strengthening supply chains as firms like Pfizer explore on shore manufacturing

3D illustration of an mRNA lipid nanoparticle releasing RNA strands into surrounding molecules.

REGULATORY

20 Nov 2025

US MRNA Leaders Push for Regulatory Modernization as Innovation Surges

Moderna, Replicate, and others accelerate mRNA advances as the US faces rising pressure to update its regulatory approach

Technicians working in an mRNA bioprocessing lab with stainless steel bioreactors.

PARTNERSHIPS

18 Nov 2025

New Alliance Aims to Steady the mRNA Supply Chain

Wacker Biotech and RNAV8 Bio join forces to streamline mRNA development and create a more predictable path to the clinic

mRNA strand connecting to virus and syringe representing genetic therapy

INNOVATION

14 Nov 2025

Can mRNA Rewrite the Future of Rare Disease Care?

US labs and biotech firms push mRNA deeper into rare disease therapy, stirring hope and investment

3D illustration of an mRNA strand, syringe, and virus particle symbolizing mRNA research.

INSIGHTS

10 Nov 2025

What BioNTech’s CureVac Deal Says About mRNA’s Future

BioNTech’s $1.25B CureVac deal pushes mRNA beyond vaccines toward cancer treatment

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.